Hoenle AG (ETR:HNL)
9.48
-0.12 (-1.25%)
Jun 10, 2026, 11:01 PM CET
Hoenle AG Earnings Call Transcripts
Fiscal Year 2026
-
Revenue and EBITDA improved sequentially, with Adhesive and Disinfection units showing growth, while Curing faced continued challenges from weak investment and customer insolvency. Full-year guidance is maintained, but expectations are toward the lower end due to market uncertainty.
-
Q1 sales and EBITDA were flat to slightly down year-over-year, with Disinfection showing strong growth while Curing lagged due to weak investment demand. Full-year guidance is maintained, with expectations for stronger performance in the second half and ongoing cost control.